drugset / Trial / NCT05742594
A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to assess the bioequivalence of four different lazertinib oral tablet formulations in healthy adult participants under fasted condition.
Timeline
- Start
- 2023-01-03
- Primary completion
- 2023-03-31
- Completion
- 2023-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lazertinib | Small molecule | — | Oral |
Indications
No indication recorded.